Skin Metastasis From Solid Tumors: Is Targeted Therapy Making an Impact?

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Dec 26

PMID 39723293

Authors

Mohamed Arshad

Ashwin J Paul

Raghul Kumar

Affiliations

Soon will be listed here.

Abstract

Cutaneous metastasis from solid tumors is a rare manifestation that presents in the clinic. It is usually indicative of poor prognosis, with a poor response to conventional chemotherapy. The introduction of targeted therapy has changed the treatment paradigm in oncology, improving the quality of life and survival of all cancer patients. Here, we present two cases of solid tumors with skin metastases that had a good response to targeted systemic therapy. This case report also discusses the various modes of presentation and the therapeutic options for metastatic cutaneous lesions from solid tumors.

References

Lookingbill D, Spangler N, Helm K . Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993; 29(2 Pt 1):228-36. DOI: 10.1016/0190-9622(93)70173-q. View

Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H . Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010; 362(25):2380-8. DOI: 10.1056/NEJMoa0909530. View

Valastyan S, Weinberg R . Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147(2):275-92. PMC: 3261217. DOI: 10.1016/j.cell.2011.09.024. View

Queiros C, Filipe P, Soares de Almeida L . Cutaneous metastases from solid neoplasms in the 21st century: a retrospective study from a Portuguese tertiary care center. J Eur Acad Dermatol Venereol. 2019; 34(6):1218-1224. DOI: 10.1111/jdv.16120. View

Saeed S, Keehn C, Morgan M . Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004; 31(6):419-30. DOI: 10.1111/j.0303-6987.2004.00207.x. View

Ivan D, Nash J, Prieto V, Calonje E, Lyle S, Diwan A . Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2007; 34(6):474-80. DOI: 10.1111/j.1600-0560.2006.00644.x. View

Finn R, Martin M, Rugo H, Jones S, Im S, Gelmon K . Palbociclib and Letrozole in Advanced Breast Cancer. N Engl J Med. 2016; 375(20):1925-1936. DOI: 10.1056/NEJMoa1607303. View

Ivan D, Diwan A, Prieto V . Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2004; 18(1):137-42. DOI: 10.1038/modpathol.3800263. View

Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P . Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian J Med Res. 2022; 156(4&5):598-607. PMC: 10231735. DOI: 10.4103/ijmr.ijmr_1821_22. View

10.

de Souza Sittart J, Senise M . Cutaneous metastasis from internal carcinomas: a review of 45 years. An Bras Dermatol. 2013; 88(4):541-4. PMC: 3760928. DOI: 10.1590/abd1806-4841.20131165. View

11.

Qureshi H, Ormsby A, Lee M, Zarbo R, Ma C . The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2003; 31(2):145-52. DOI: 10.1111/j.0303-6987.2004.00147.x. View

12.

Wick M, Swanson P, Ritter J, Fitzgibbon J . The immunohistology of cutaneous neoplasia: a practical perspective. J Cutan Pathol. 1993; 20(6):481-97. DOI: 10.1111/j.1600-0560.1993.tb00676.x. View